Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

Pathway-based biomarker search by high-throughput proteomics profiling of secretomes.

Lawlor K, Nazarian A, Lacomis L, Tempst P, Villanueva J.

J Proteome Res. 2009 Mar;8(3):1489-503. doi: 10.1021/pr8008572.

PMID:
19199430
2.

Workflow comparison for label-free, quantitative secretome proteomics for cancer biomarker discovery: method evaluation, differential analysis, and verification in serum.

Piersma SR, Fiedler U, Span S, Lingnau A, Pham TV, Hoffmann S, Kubbutat MH, Jiménez CR.

J Proteome Res. 2010 Apr 5;9(4):1913-22. doi: 10.1021/pr901072h.

PMID:
20085282
3.

Proteomic approaches to biomarker discovery in prostate and bladder cancers.

Adam BL, Vlahou A, Semmes OJ, Wright GL Jr.

Proteomics. 2001 Oct;1(10):1264-70. Review.

PMID:
11721637
4.

Cancer proteomics: from biomarker discovery to signal pathway profiling.

Bichsel VE, Liotta LA, Petricoin EF 3rd.

Cancer J. 2001 Jan-Feb;7(1):69-78. Review.

PMID:
11269650
5.

Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast.

Gromov P, Gromova I, Bunkenborg J, Cabezon T, Moreira JM, Timmermans-Wielenga V, Roepstorff P, Rank F, Celis JE.

Mol Oncol. 2010 Feb;4(1):65-89. doi: 10.1016/j.molonc.2009.11.003.

6.

Entering a new era of rational biomarker discovery for early detection of melanoma metastases: secretome analysis of associated stroma cells.

Paulitschke V, Kunstfeld R, Mohr T, Slany A, Micksche M, Drach J, Zielinski C, Pehamberger H, Gerner C.

J Proteome Res. 2009 May;8(5):2501-10. doi: 10.1021/pr8010827.

PMID:
19222175
7.

A web-based tool for in silico biomarker discovery based on tissue-specific protein profiles in normal and cancer tissues.

Björling E, Lindskog C, Oksvold P, Linné J, Kampf C, Hober S, Uhlén M, Pontén F.

Mol Cell Proteomics. 2008 May;7(5):825-44.

9.

Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.

Sardana G, Jung K, Stephan C, Diamandis EP.

J Proteome Res. 2008 Aug;7(8):3329-38. doi: 10.1021/pr8003216.

PMID:
18578523
10.

Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes.

Wu CC, Chen HC, Chen SJ, Liu HP, Hsieh YY, Yu CJ, Tang R, Hsieh LL, Yu JS, Chang YS.

Proteomics. 2008 Jan;8(2):316-32. doi: 10.1002/pmic.200700819.

PMID:
18203259
11.

Unconventional secretion is a major contributor of cancer cell line secretomes.

Villarreal L, Méndez O, Salvans C, Gregori J, Baselga J, Villanueva J.

Mol Cell Proteomics. 2013 May;12(5):1046-60. doi: 10.1074/mcp.M112.021618.

12.

Molecular alterations associated with bladder cancer initiation and progression.

Cordon-Cardo C.

Scand J Urol Nephrol Suppl. 2008 Sep;(218):154-65. doi: 10.1080/03008880802291915. Review.

PMID:
18815930
13.

Characterization of de novo synthesized proteins released from human colorectal tumour explants.

Shi HJ, Stubbs R, Hood K.

Electrophoresis. 2009 Jul;30(14):2442-53. doi: 10.1002/elps.200800767.

PMID:
19639566
14.

Secretome compartment is a valuable source of biomarkers for cancer-relevant pathways.

Caccia D, Zanetti Domingues L, Miccichè F, De Bortoli M, Carniti C, Mondellini P, Bongarzone I.

J Proteome Res. 2011 Sep 2;10(9):4196-207. doi: 10.1021/pr200344n.

PMID:
21751813
15.

Identification of pathways associated with invasive behavior by ovarian cancer cells using multidimensional protein identification technology (MudPIT).

Sodek KL, Evangelou AI, Ignatchenko A, Agochiya M, Brown TJ, Ringuette MJ, Jurisica I, Kislinger T.

Mol Biosyst. 2008 Jul;4(7):762-73. doi: 10.1039/b717542f.

PMID:
18563251
16.

Analysis of secreted proteins for the study of bladder cancer cell aggressiveness.

Makridakis M, Roubelakis MG, Bitsika V, Dimuccio V, Samiotaki M, Kossida S, Panayotou G, Coleman J, Candiano G, Anagnou NP, Vlahou A.

J Proteome Res. 2010 Jun 4;9(6):3243-59. doi: 10.1021/pr100189d.

PMID:
20423150
17.

Proteomics-driven cancer biomarker discovery: looking to the future.

Simpson RJ, Bernhard OK, Greening DW, Moritz RL.

Curr Opin Chem Biol. 2008 Feb;12(1):72-7. doi: 10.1016/j.cbpa.2008.02.010. Review.

PMID:
18295612
18.

Novel comprehensive approach for accessible biomarker identification and absolute quantification from precious human tissues.

Turtoi A, Dumont B, Greffe Y, Blomme A, Mazzucchelli G, Delvenne P, Mutijima EN, Lifrange E, De Pauw E, Castronovo V.

J Proteome Res. 2011 Jul 1;10(7):3160-82. doi: 10.1021/pr200212r.

PMID:
21534635
19.

Cell secretome analysis using hollow fiber culture system leads to the discovery of CLIC1 protein as a novel plasma marker for nasopharyngeal carcinoma.

Chang YH, Wu CC, Chang KP, Yu JS, Chang YC, Liao PC.

J Proteome Res. 2009 Dec;8(12):5465-74. doi: 10.1021/pr900454e.

PMID:
19845400
20.

Identification of proteins secreted by head and neck cancer cell lines using LC-MS/MS: Strategy for discovery of candidate serological biomarkers.

Ralhan R, Masui O, Desouza LV, Matta A, Macha M, Siu KW.

Proteomics. 2011 Jun;11(12):2363-76. doi: 10.1002/pmic.201000186.

PMID:
21598386

Supplemental Content

Support Center